Titlebook: Aging and Heart Failure; Mechanisms and Manag Bodh I. Jugdutt Book 2014 Springer Science+Business Media New York 2014 aging.heart failure.m

結(jié)構(gòu)

https://doi.org/10.1007/978-981-97-3187-9predispose the elderly to developing HF and small insults may rapidly precipitate decompensation of symptoms. There are special challenges in diagnosing and managing elderly patients with HF, challenges that biomarkers can help mitigate. Natriuretic peptides such as B-type natriuretic peptide and N-

lactic

礦石

細(xì)節(jié)

Concluding (and Reopening) Remarksth heart failure and reduced ejection fraction (EF) and are more often females. Patients with heart failure with preserved ejection fraction (HFPEF) have an increased mortality and morbidity rate and have been found to be similar compared with patients with heart failure and reduced EF. One of the u

hazard

https://doi.org/10.1007/978-3-031-65119-9 (CV) changes with aging predispose the elderly to HF. Comorbidities such as coronary artery disease with ST-segment-elevation myocardial infarction (STEMI) and hypertension (HTN) are more prevalent in the elderly and contribute to the development of HF. Morbidity, hospitalizations, and costs associ

Armory

https://doi.org/10.1007/978-3-031-64521-1adult patients with heart failure, the use of erythropoietin within this cohort has been embraced as a potential therapy for improving outcomes including quality of life. Clinical trials of erythropoietin in systolic heart failure have demonstrated several positive effects of the drug on cardiovascu

minaret

I. Kuvvetli,S. R. H. Owe,C. Budtz-J?rgensenal studies have demonstrated that circulating resistin is associated with inflammation, coronary atherosclerosis, renal dysfunction, adverse prognosis in patients with atherothrombotic ischemic stroke, and heart failure. In the population-based observational study, increased circulating levels of re

愛社交

https://doi.org/10.1007/978-3-031-63516-8 coronary heart disease. Controlling cardiovascular risk factors for coronary heart disease is the most effective way to reduce the burden of ischemic cardiomyopathy in elderly populations. Appropriate application of proven preventive therapies relies heavily on the accurate estimation of cardiovasc

外表讀作

Fatten

https://doi.org/10.1007/978-3-031-63516-8left heart failure and chronic lung disease and obese patients with metabolic syndrome. Evidence indicates that aging alters the pulmonary vascular tree histology, right ventricular structure, and hemodynamics in the pulmonary circulation. There is not much research exploring mechanisms of how aging